Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares RepurchasedShort-Term Debt repayments
Ratios

Ani Pharmaceuticals (ANIP) Shares Issued (2016 - 2025)

Historic Shares Issued for Ani Pharmaceuticals (ANIP) over the last 16 years, with Q3 2025 value amounting to $9.8 million.

  • Ani Pharmaceuticals' Shares Issued rose 72130.87% to $9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.3 million, marking a year-over-year increase of 21883.88%. This contributed to the annual value of $6.5 million for FY2024, which is 9194.59% down from last year.
  • Ani Pharmaceuticals' Shares Issued amounted to $9.8 million in Q3 2025, which was up 72130.87% from $1.2 million recorded in Q2 2025.
  • In the past 5 years, Ani Pharmaceuticals' Shares Issued ranged from a high of $80.4 million in Q2 2023 and a low of $3000.0 during Q1 2022
  • Moreover, its 5-year median value for Shares Issued was $1.2 million (2024), whereas its average is $11.4 million.
  • Its Shares Issued has fluctuated over the past 5 years, first skyrocketed by 4087514.79% in 2021, then tumbled by 9889.09% in 2022.
  • Quarter analysis of 5 years shows Ani Pharmaceuticals' Shares Issued stood at $69.2 million in 2021, then crashed by 98.89% to $768000.0 in 2022, then soared by 10368.49% to $80.4 million in 2023, then tumbled by 97.89% to $1.7 million in 2024, then soared by 475.88% to $9.8 million in 2025.
  • Its last three reported values are $9.8 million in Q3 2025, $1.2 million for Q2 2025, and $2.5 million during Q1 2025.